| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $9,888,007 ) (Continued on the next page) |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | T34GM142609 | Bridges to the Baccalaureate Research Training Program at Kansas State University | 000 | 4 | NIH | 8/14/2024 | $277,251 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U01FD007132 | Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens in Kansas as a Part of the National Antimicrobial Resistance Monitoring System | 002 | 5 | FDA | 9/2/2024 | $185,000 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | P20GM130448 | Center on Emerging and Zoonotic Infectious Diseases | 000 | 5 | NIH | 5/14/2024 | $2,256,646 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM140852 | Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci | 001 | 4 | NIH | 8/6/2024 | $36,331 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM140852 | Novel Enzyme Inhibitors in the Innate Immune Evasion Repertoire of Staphylococci | 000 | 4 | NIH | 2/13/2024 | $326,981 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM141859 | Function of hemolymph plasma proteins in insect immune responses | 002 | 4 | NIH | 7/30/2024 | $37,671 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM141859 | Function of hemolymph plasma proteins in insect immune responses | 001 | 4 | NIH | 2/14/2024 | $6,808 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM141859 | Function of hemolymph plasma proteins in insect immune responses | 000 | 4 | NIH | 2/13/2024 | $339,039 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 002 | 4 | NIH | 6/11/2024 | $14,528 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 001 | 4 | NIH | 3/20/2024 | $0 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | T35OD029981 | Short Term Training in Health Professional Schools | 000 | 4 | NIH | 2/13/2024 | $51,344 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AI146930 | Virulence Mechanisms of Multifunctional Borrelial Proteins | 002 | 6 | NIH | 8/14/2024 | $594,545 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01NS112506 | Molecular Regulation of LRRK2 in Parkinson's Disease | 001 | 5 | NIH | 4/22/2024 | $25,113 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01NS112506 | Molecular Regulation of LRRK2 in Parkinson's Disease | 000 | 5 | NIH | 11/22/2023 | $322,875 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006376 | CVM VetLIRN Veterinary Diagnostic Laboratory Program for Kansas State University | 005 | 7 | FDA | 5/13/2024 | $53,200 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006376 | CVM VetLIRN Veterinary Diagnostic Laboratory Program for Kansas State University | 006 | 7 | FDA | 5/21/2024 | $0 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AI130092 | Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential | 002 | 6 | NIH | 9/3/2024 | $73,431 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AI130092 | Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential | 001 | 6 | NIH | 7/19/2024 | $699,892 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM124828 | Molecular control of microRNA gene-regulatory activity. | 001 | 6 | NIH | 4/1/2024 | $447,346 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | P20GM113109 | Cognitive and Neurobiological Approaches to Plasticity (CNAP) Center Phase 2 | 001 | 8 | NIH | 5/31/2024 | $2,250,623 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AR060788 | Mechanisms Underlying Muscle Development and Maintenance in Drosophila | 001 | 11 | NIH | 6/11/2024 | $22,847 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AR060788 | Mechanisms Underlying Muscle Development and Maintenance in Drosophila | 000 | 11 | NIH | 12/12/2023 | $293,749 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01HL166591 | Role of Adiponectin in Reversal of Age-related Vascular Dysfunction | 003 | 3 | NIH | 8/27/2024 | $322,722 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | F31HL167618 | ROLE OF ANGIOTENSIN-(1-7) AND DIAPHRAGM VASCULAR FUNCTION IN HEART FAILURE AND PROLONGED MECHANICAL VENTILATION | 000 | 2 | NIH | 12/14/2023 | $35,480 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R35GM155117 | Neuronal regulation of tissue-resident macrophage maintenance and polarization | 000 | 1 | NIH | 6/14/2024 | $375,659 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | F31HL170643 | Role for Nrf2 and exercise in mitigating pulmonary hypertension-induced vascular dysfunction | 000 | 2 | NIH | 8/22/2024 | $36,922 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01GM147542 | Mechanism of stringent translation initiation: a probe for its biological relevance | 000 | 2 | NIH | 6/24/2024 | $297,185 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R03DA057525 | Behavioral compensation in goal-directed action: Long term effects of voluntary methamphetamine taking versus passive exposure | 000 | 2 | NIH | 8/14/2024 | $71,063 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R03OH012318 | Listening while wearing hearing protection: performance dynamics, choice to wear, and impacts of training | 00 | 2 | CDC | 6/26/2024 | $76,000 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R21AI173784 | Defining the ability of HPV oncogenes to promote mutagenesis | 000 | 2 | NIH | 7/1/2024 | $190,000 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD008360 | Assessing correlation between antimicrobial resistance genes and susceptibility phenotypes for Enterobacter cloacae complex isolates from the Vet-LIRN AMR monitoring program and clinical samples | 000 | 1 | FDA | 8/7/2024 | $50,000 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R03MH133173 | Understanding the role of the frontal cortex during cognitive flexibility in Fmr1 knock outs | 001 | 2 | NIH | 8/12/2024 | $7,159 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R03MH133173 | Understanding the role of the frontal cortex during cognitive flexibility in Fmr1 knock outs | 000 | 2 | NIH | 2/15/2024 | $64,430 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01HL161160 | Signaling pathways regulating mechanoreflex sensitization in cardiovascular disease | 000 | 3 | NIH | 6/7/2024 | $511,705 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01AG075012 | The role of prior knowledge and event segmentation in age- and Alzheimer's-related changes in event memory | 000 | 3 | NIH | 7/9/2024 | $395,031 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R34MH126043 | Physical Activity to Reduce Cardiometabolic Risk in Adults with Serious Mental Illness (PARCS Study) | 001 | 3 | NIH | 7/22/2024 | $22,355 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R34MH126043 | Physical Activity to Reduce Cardiometabolic Risk in Adults with Serious Mental Illness (PARCS Study) | 000 | 3 | NIH | 2/21/2024 | $201,194 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01GM141235 | Structure-function properties in liquid organelles | 000 | 4 | NIH | 4/15/2024 | $281,811 |
| | 2024 | 2024 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R01GM141235 | Structure-function properties in liquid organelles | 001 | 4 | NIH | 7/15/2024 | $31,312 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | R03AI165428 | Bacterial Targets of T3SS Effector Proteases | 000 | 2 | NIH | 6/25/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U01FD007132 | Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens in Kansas as a Part of the National Antimicrobial Resistance Monitoring System | 001 | 4 | FDA | 4/2/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U01FD007132 | Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens in Kansas as a Part of the National Antimicrobial Resistance Monitoring System | 000 | 4 | FDA | 2/10/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006915 | Method validation for the analysis of cannabinoids in animal specimen and hemp-based animal feed products | 000 | 4 | FDA | 7/15/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD008005 | Multi-lab validation of a real-time PCR assay for detection and surveillance of SARS-CoV-2 for companion animal applications. | 000 | 1 | FDA | 7/15/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006376 | CVM VetLIRN Veterinary Diagnostic Laboratory Program for Kansas State University | 004 | 6 | FDA | 4/27/2024 | $65,619 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006376 | CVM VetLIRN Veterinary Diagnostic Laboratory Program for Kansas State University | 000 | 6 | FDA | 4/2/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD006376 | CVM VetLIRN Veterinary Diagnostic Laboratory Program for Kansas State University | 001 | 6 | FDA | 4/5/2024 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | P20GM113109 | Cognitive and Neurobiological Approaches to Plasticity (CNAP) Center Phase 2 | 000 | 7 | NIH | 12/21/2023 | $0 |
| | 2024 | 2023 | KANSAS STATE UNIVERSITY | 1601 VATTIER STREET | MANHATTAN | KS | 66506-2504 | RILEY | USA | U18FD007516 | Detection of SARS-CoV-2 and characterization of SARS-CoV-2 S-gene in major companion and food animals | 000 | 3 | FDA | 7/9/2024 | $0 |
|
